Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome-Results from the countrywide TARGET study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 922-927

  Andrikopoulos, G ^a   Tzeis, S ^a   Nikas, N ^b   Richter, D ^c   Pipilis, A ^d   Gotsis, A ^e   Tsaknakis, T ^f   Kartalis, A ^g   Kitsiou, A ^h   Toli, K ⁱ   Mantas, I ⁱ   Olympios, C ^j   Pras, A ^k   Lampropoulos, S ^l   Oikonomou, K ^m   Pappas, C ^o   Kranidis, A ⁿ   Anastasiou Nana, M ^o   Triposkiadis, F ^p   Goudevenos, I ^q   Theodorakis, G ^a   Vardas, P ^r   more..

^a HENRY DUNANT HOSPITAL   (Greece)

^b ASTRAZENECA   (United Kingdom)

^c Athens Euroclinic   (Greece)

^d HYGEIA HOSPITAL   (Greece)

^e General Hospital of Komotini   (Greece)

^f Achilopouleio General Hospital of Volos   (Greece)

^g Chios General Hospital   (Greece)

^h SISMANOGLIO HOSPITAL   (Greece)

ⁱ General Hospital of Halkida   (Greece)

^j THRIASIO GENERAL HOSPITAL   (Greece)

^k General Hospital of Chania   (Greece)

^l Bodosakeio General Hospital of Ptolemaida   (Greece)

^m General Hospital of Edessa   (Greece)

ⁿ Western Attica General Hospital   (Greece)

^o NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^p UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^q UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^r UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

more..

Author keywords

Acute coronary syndrome; Outcome; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIVITAMIN K; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING CESSATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; OUTCOME; SECONDARY PREVENTION;

ACUTE CORONARY SYNDROME; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GOALS; GREECE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885295143     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.049     Document Type: Article

References (27)

1. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362: 2155-65.
2. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-93.
3. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32(23):2999-3054.
4. Hutchinson-Jaffe AB, Goodman SG, Yan RT, et al. Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials. Am J Cardiol 2010;106(10): 1389-96.
5. Andrikopoulos G, Tzeis S, Mantas I, et al. Epidemiological characteristics and in-hospital management of acute coronary syndrome patients in Greece-results from the TARGET study. Hellenic J Cardiol 2012;53(1):33-40.
6. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. Circulation 2003;108:2543-9.
7. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
8. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47.
9. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
10. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110(2):227-39.
11. Andrikopoulos G, Pipilis A, Goudevenos J, et al. Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study. Hellenic J Cardiol 2007;48(6):325-34.
12. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: ameta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319-25.
13. O'Donoghue M, Boden WE, Braunwald E, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008;300:71-80.
14. Fox KA, Clayton TC, Damman P, et al. Long-termoutcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. JAmColl Cardiol 2010;55:2435-45.
15. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol 2008;51:1247-54.
16. Granger CB, Steg PG, Peterson E, et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med 2005;118:858-65.
17. Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics and 1-year outcome. Am Heart J 2007;154(6):1108-15.
18. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-9.
19. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7.
20. Yan AT, Yan RT, Lee CH, et al. Optimal medical therapy for non-STsegment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circ Cardiovasc Qual Outcomes 2010;3(5):530-7.
21. Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004;117:73-81.
22. Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J 2009;157(3):509-16.
23. Reiner Z, Catapano AL, BackerG De, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32(14):1769-818.
24. Melloni C, Shah BR, Ou FS, et al. Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry. Am Heart J 2010;160(6):1121-9.
25. Chew DP, Huynh LT, Liew D, Astley C, Soman A, Brieger D. Potential survival gains in the treatment of myocardial infarction. Heart 2009;95:1844-50.
26. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
27. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121:750-8.